K. Zerfass
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 2
- RNA Interference and Gene Delivery 2
- Genomics and Phylogenetic Studies 1
- RNA and protein synthesis mechanisms 1
- RNA Research and Splicing 1
- Oncology 5
- Cancer-related Molecular Pathways 5
- Co-authors
- Pidder Jansen‐Dürr (6 shared papers)Berthold Henglein (4 shared papers)Almut Schulze (4 shared papers)Dimitry Spitkovsky (4 shared papers)Kristian Helin (1 shared paper)Sabine Middendorp (1 shared paper)J Bergès (1 shared paper)Hildburg Beier (1 shared paper)
- Journals
- Journal of Virology (2 papers)Proceedings of the National Academy of Sciences (1 paper)IUBMB Life (1 paper)Journal of General Virology (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
K. Zerfass
9 papers receiving 727 citations
Peers
Comparison fields: 5 of 69
- Oncology 394
- Molecular Biology 499
- Cell Biology 77
- Epidemiology 133
- Genetics 116
Countries citing papers authored by K. Zerfass
This map shows the geographic impact of K. Zerfass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Zerfass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Zerfass more than expected).
Fields of papers citing papers by K. Zerfass
This network shows the impact of papers produced by K. Zerfass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Zerfass. The network helps show where K. Zerfass may publish in the future.
Co-authors
The 22 scholars most cited alongside K. Zerfass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 330 | |
| 2 | 1995 | 163 | |
| 3 | 1992 | 79 | |
| 4 | 1992 | 49 | |
| 5 | Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. | 1994 | 43 |
| 6 | Transcriptional control of the Htf9-A/RanBP-1 gene during the cell cycle. | 1995 | 32 |
| 7 | 1996 | 31 | |
| 8 | 1995 | 24 | |
| 9 | 1997 | 9 |
About K. Zerfass
K. Zerfass is a scholar working on Molecular Biology, Oncology, Genetics, Ecology and Epidemiology, having authored 9 papers that have together received 760 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Virus-based gene therapy research (4 papers), RNA modifications and cancer (2 papers), RNA Interference and Gene Delivery (2 papers), Genomics and Phylogenetic Studies (1 paper), RNA and protein synthesis mechanisms (1 paper), Cervical Cancer and HPV Research (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Oncology (394 citations), Molecular Biology (499 citations), Cell Biology (77 citations), Epidemiology (133 citations) and Genetics (116 citations). K. Zerfass has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Pidder Jansen‐Dürr, Berthold Henglein, Almut Schulze, Dimitry Spitkovsky, Kristian Helin, Sabine Middendorp, J Bergès, Hildburg Beier, Varda Friedman and H. Beier. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, IUBMB Life, Journal of General Virology and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.